The Renaissance of Cyclin Dependent Kinase Inhibitors

SIMPLE SUMMARY: This review provides an overview of the state of knowledge and general understanding of CDK inhibitors currently under development or clinically approved, with a particular focus on the treatment of head and neck cancer. Especially in combination therapy, cyclin-dependent kinase inhi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ettl, Tobias, Schulz, Daniela, Bauer, Richard Josef
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773807/
https://www.ncbi.nlm.nih.gov/pubmed/35053461
http://dx.doi.org/10.3390/cancers14020293

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773807/
https://www.ncbi.nlm.nih.gov/pubmed/35053461
http://dx.doi.org/10.3390/cancers14020293

Ejemplares similares